Kevin Davies is the founding editor of Bio-IT World and Nature Genetics, and the author of The $1,000 Genome (Free Press, 2010), an account of the revolution in DNA sequencing technologies, personal genomics, and personalized medicine.
Dr. Larry Gold is the Founder and Chairman Emeritus of the Board, and former CEO of SomaLogic. Prior to SomaLogic, he also founded and was the Chairman of NeXagen, Inc., which later became NeXstar Pharmaceuticals, Inc. In 1999, NeXstar merged with Gilead Sciences, Inc. to form a global organization committed to the discovery, development and commercialization of novel products that treat infectious diseases.
Dr. Larry Gold is the Founder and Chairman Emeritus of the Board, and former CEO of SomaLogic. Prior to SomaLogic, he also founded and was the Chairman of NeXagen, Inc., which later became NeXstar Pharmaceuticals, Inc. In 1999, NeXstar merged with Gilead Sciences, Inc. to form a global organization committed to the discovery, development and commercialization of novel products that treat infectious diseases.
Gold Lab
University of Colorado Boulder
347 UCB
Boulder, CO 80309
Email: info@goldlabfoundation.org
